Mitigating arrhythmia risk in Hydroxychloroquine and Azithromycin treated COVID-19 patients using arrhythmia risk management plan.
Maneikis K, Ringeleviciute U, Bacevicius J, Dieninyte-Misiune E, Burokaite E, Kazbaraite G, Monika Janusaite M, Dapkeviciute A, Zucenka A, Peceliunas V, Kryzauskaite L, Kasiulevicius V, Ringaitiene D, Zablockiene B, Zvirblis T, Marinskis G, Jancoriene L, Griskevicius L.
Maneikis K, et al. Among authors: kasiulevicius v.
Int J Cardiol Heart Vasc. 2020 Dec 11;32:100685. doi: 10.1016/j.ijcha.2020.100685. eCollection 2021 Feb.
Int J Cardiol Heart Vasc. 2020.
PMID: 33335973
Free PMC article.